Style | Citing Format |
---|---|
MLA | Tashrifi Z, et al.. "Design, Synthesis and in Vitro Cytotoxicity of New 1,2,3-Triazol-And Nitrostyrene Hybrids As Potent Anticancer Agents." Letters in Drug Design and Discovery, vol. 16, no. 2, 2018, pp. 213-219. |
APA | Tashrifi Z, Mohammadikhanaposhtani M, Ardestani MS, Safavi M, Radmoghadam K, Mehrdad M, Larijani B, Mahdavi M (2018). Design, Synthesis and in Vitro Cytotoxicity of New 1,2,3-Triazol-And Nitrostyrene Hybrids As Potent Anticancer Agents. Letters in Drug Design and Discovery, 16(2), 213-219. |
Chicago | Tashrifi Z, Mohammadikhanaposhtani M, Ardestani MS, Safavi M, Radmoghadam K, Mehrdad M, Larijani B, Mahdavi M. "Design, Synthesis and in Vitro Cytotoxicity of New 1,2,3-Triazol-And Nitrostyrene Hybrids As Potent Anticancer Agents." Letters in Drug Design and Discovery 16, no. 2 (2018): 213-219. |
Harvard | Tashrifi Z et al. (2018) 'Design, Synthesis and in Vitro Cytotoxicity of New 1,2,3-Triazol-And Nitrostyrene Hybrids As Potent Anticancer Agents', Letters in Drug Design and Discovery, 16(2), pp. 213-219. |
Vancouver | Tashrifi Z, Mohammadikhanaposhtani M, Ardestani MS, Safavi M, Radmoghadam K, Mehrdad M, et al.. Design, Synthesis and in Vitro Cytotoxicity of New 1,2,3-Triazol-And Nitrostyrene Hybrids As Potent Anticancer Agents. Letters in Drug Design and Discovery. 2018;16(2):213-219. |
BibTex | @article{ author = {Tashrifi Z and Mohammadikhanaposhtani M and Ardestani MS and Safavi M and Radmoghadam K and Mehrdad M and Larijani B and Mahdavi M}, title = {Design, Synthesis and in Vitro Cytotoxicity of New 1,2,3-Triazol-And Nitrostyrene Hybrids As Potent Anticancer Agents}, journal = {Letters in Drug Design and Discovery}, volume = {16}, number = {2}, pages = {213-219}, year = {2018} } |
RIS | TY - JOUR AU - Tashrifi Z AU - Mohammadikhanaposhtani M AU - Ardestani MS AU - Safavi M AU - Radmoghadam K AU - Mehrdad M AU - Larijani B AU - Mahdavi M TI - Design, Synthesis and in Vitro Cytotoxicity of New 1,2,3-Triazol-And Nitrostyrene Hybrids As Potent Anticancer Agents JO - Letters in Drug Design and Discovery VL - 16 IS - 2 SP - 213 EP - 219 PY - 2018 ER - |